CXCR4 and pulmonary fibrosis: We found that AMD3100 inhibited MMP19-induced monocyte adhesion to HPMECs and CXCR4+ monocyte accumulation in lung tissues, and alleviated MMP19-induced exacerbation of BLM-induced pulmonary fibrosis.